Both Vyvgart and Ultomiris are FDA-approved treatments for myasthenia gravis, but individual responses can vary. Here are some details to consider:

Vyvgart (Efgartigimod alfa-fcab)
- Common Side Effects: Respiratory tract infections, injection site reactions
- Serious Side Effects: Hives, difficulty breathing, severe Show Full Answer

Both Vyvgart and Ultomiris are FDA-approved treatments for myasthenia gravis, but individual responses can vary. Here are some details to consider:

Vyvgart (Efgartigimod alfa-fcab)
- Common Side Effects: Respiratory tract infections, injection site reactions.
- Serious Side Effects: Hives, difficulty breathing, severe dizziness, fever, sore throat, swelling of face, lips, tongue, or throat.

Ultomiris (Ravulizumab-cwvz)
- Common Side Effects: Diarrhea, upper respiratory tract infection.
- Serious Side Effects: Meningococcal infections, infusion-related reactions (including anaphylaxis), lower back pain, changes in blood pressure, pain in arms and legs, drug hypersensitivity, unpleasant taste, drowsiness.

Administration
- Vyvgart: Administered via injection.
- Ultomiris: Administered via IV or subcutaneous injection every eight weeks, starting two weeks after the first dose.

Personal Experiences
- Vyvgart: 69 people have indicated they have taken it.
- Ultomiris: 27 people have indicated they have taken it.

For more personalized experiences, you might want to visit the respective treatment pages on MGteam:
- [Vyvgart](https://www.MGteam.com/treatments/vyvgart)
- [Ultomiris](https://www.MGteam.com/treatments/ultomiris)

Always consult with your healthcare provider before making any changes to your treatment plan.

 This AI-generated response comes from MGteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Ultomiris (Ravulizumab-cwvz) for Myasthenia Gravis | MGteam

Vyvgart (Efgartigimod alfa-fcab) for Myasthenia Gravis | MGteam